Hydrophobicity maps and docking of molecular fragments with solvation

被引:8
作者
Majeux, N [1 ]
Scarsi, M [1 ]
Tenette-Souaille, C [1 ]
Caflisch, A [1 ]
机构
[1] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland
关键词
continuum electrostatics; docking of fragment library; generalized Born approximation; hydrophobicity map; molecular surface; p38 MAP kinase; SEED; solvation; thrombin;
D O I
10.1023/A:1008785123705
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two methods for structure-based computational ligand design are reviewed. Hydrophobicity maps allow to quantitatively estimate and graphically display the propensity of nonpolar groups to bind at the surface of a protein target [Scarsi et al., Proteins Struct. Funct. Genet., 37 (1999) 565]. The program SEED (Solvation Energy for Exhaustive Docking) finds optimal positions and orientations of nonpolar fragments using the hydrophobicity maps, while polar fragments are docked with at least one hydrogen bond with the protein [Majeux et al., Proteins Struct. Funct. Genet., 37 (1999) 88]. An efficient evaluation of the binding energy, including continuum electrostatic solvation, allows to dock a library of 100 fragments into a 25-residue binding site in about five hours on a personal computer. Applications to thrombin, a key enzyme in the blood coagulation cascade, and the p38 mitogen-activated protein kinase, which is a target for the treatment of inflammatory and neurodegenerative diseases, are presented. The role of the hydrophobicity maps and structure-based docking of a fragment library in exploiting genomes to design drugs is addressed.
引用
收藏
页码:145 / 169
页数:25
相关论文
共 95 条
[81]   STRUCTURE-BASED DISCOVERY OF INHIBITORS OF THYMIDYLATE SYNTHASE [J].
SHOICHET, BK ;
STROUD, RM ;
SANTI, DV ;
KUNTZ, ID ;
PERRY, KM .
SCIENCE, 1993, 259 (5100) :1445-1450
[82]   Discovering high-affinity ligands for proteins: SAR by NMR [J].
Shuker, SB ;
Hajduk, PJ ;
Meadows, RP ;
Fesik, SW .
SCIENCE, 1996, 274 (5292) :1531-1534
[83]   A comparative study of ligand-receptor complex binding affinity prediction methods based on glycogen phosphorylase inhibitors [J].
So, SS ;
Karplus, M .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1999, 13 (03) :243-258
[84]   SEMIANALYTICAL TREATMENT OF SOLVATION FOR MOLECULAR MECHANICS AND DYNAMICS [J].
STILL, WC ;
TEMPCZYK, A ;
HAWLEY, RC ;
HENDRICKSON, T .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (16) :6127-6129
[85]  
STUBBS MT, 1993, PERSPECT DRUG DISCOV, V1, P431
[86]   INHIBITION OF BOVINE AND HUMAN THROMBINS BY DERIVATIVES OF BENZAMIDINE [J].
STURZEBECHER, J ;
WALSMANN, P ;
VOIGT, B ;
WAGNER, G .
THROMBOSIS RESEARCH, 1984, 36 (05) :457-465
[87]   STRUCTURE OF A RETRO-BINDING PEPTIDE INHIBITOR COMPLEXED WITH HUMAN ALPHA-THROMBIN [J].
TABERNERO, L ;
CHANG, CYY ;
OHRINGER, SL ;
LAU, WF ;
IWANOWICZ, EJ ;
HAN, WC ;
WANG, TC ;
SEILER, SM ;
ROBERTS, DGM ;
SACK, JS .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 246 (01) :14-20
[88]   SYNTHETIC LOW-MOLECULAR-WEIGHT THROMBIN INHIBITORS - MOLECULAR DESIGN AND PHARMACOLOGICAL PROFILE [J].
TAPPARELLI, C ;
METTERNICH, R ;
EHRHARDT, C ;
COOK, NS .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (10) :366-376
[89]   A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket [J].
Tong, L ;
Pav, S ;
White, DM ;
Rogers, S ;
Crane, KM ;
Cywin, CL ;
Brown, ML ;
Pargellis, CA .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (04) :311-316
[90]  
Vorobjev YN, 1998, PROTEINS, V32, P399, DOI 10.1002/(SICI)1097-0134(19980901)32:4<399::AID-PROT1>3.3.CO